ADAGIO THERAPEUTICS INC (ADGI) Stock Earnings & Estimates
USA - NASDAQ:ADGI - US00534A1025 - Common Stock
4.64 USD
+0.04 (+0.87%)
4.52 USD
-0.12 (-2.59%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 1,233.34% | N/A 145.10% | N/A 150.00% | |||
| EBITDA YoY % growth | N/A | -226.907M | N/A 3.35% | N/A 2.33% | N/A 56.26% | N/A -26.76% | N/A -29.29% | |
| EBIT YoY % growth | -65.327M | -226.908M -247.34% | N/A -12.80% | N/A 8.82% | N/A 36.34% | N/A -20.18% | N/A -22.58% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A -2.35% | N/A 17.36% | N/A 30.42% | N/A -21.46% | N/A -23.89% |
All data in USD
| Q3 / 22 | Q4 / 22 | |
|---|---|---|
| EPS Q2Q % growth | -0.50 48.65% | -0.53 31.56% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -55.225M 8.60% | -57.568M 30.72% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.47 -161.11% | -0.58 | 0.11 | 19.16% |
| Q1 2022 Q2Q % growth | -0.93 | -0.83 | -0.10 | -11.53% |
| Q4 2021 Q2Q % growth | -0.77 | -1.05 | 0.28 | 26.89% |
| Q3 2021 Q2Q % growth | -0.98 | -0.75 | -0.23 | -30.28% |
| Q2 2021 Q2Q % growth | -0.18 | -0.81 | 0.63 | 77.87% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |